Benign Hematology

Las Vegas Hematologic Malignancies Symposium

The Las Vegas Hematologic Malignancies Symposium aims to enhance participants’ knowledge and competence in applying practice-changing clinical data and expert recommendations to optimize outcomes for patients with hematologic malignancies.

North Carolina Hematologic Malignancies Symposium

The North Carolina Hematologic Malignancies Symposium aims to enhance participants’ knowledge and competence in applying practice-changing clinical data and expert recommendations to optimize outcomes for patients with hematologic malignancies.

2025 Nebraska Congress on Hematologic Malignancies: Recent Advances and Cellular Therapy

The 2025 Nebraska Congress on Hematologic Malignancies: Recent Advances and Cellular Therapy is a one-day CME-accredited, in-person conference that convenes leading experts to discuss the latest advances in the management of benign and malignant hematologic disorders.

Upstate New York Hematology & Hematologic Oncology Conference: Updates from the 65th ASH Annual Meeting

This CME-accredited activity, the Upstate New York Hematology & Hematologic Oncology Conference: Updates from the 65th ASH Annual Meeting, is a two-day symposium designed to provide an engaging and interactive forum for discussing the latest breakthroughs in benign and

BTF’s ASH Annual Meeting Review 2023 - Portland

The BTF’s ASH Annual Meeting Review 2023 - Portland is a CME-accredited, in-person hematology conference featuring leading experts in the field.

2022 Highlights of ASH

The 2022 Highlights of ASH will take place in Coeur d'Alene, Idaho on February 19, 2021. This hematology conference includes review of key abstracts presented at the American Society of Hematology 63rd ASH Annual Meeting and expert faculties will put those findings into clinical context to help clinicians apply those into clinical practice.